Jane Street
KRTX

Jane Street’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jane Street’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127,600
Closed -$40.4M – 10353
2023
Q4 		$40.4M Buy
127,600
+105,200
+470% +$20.4M 0.01% 790
2023
Q3 		$3.79M Sell
22,400
-73,100
-77% -$13.7M ﹤0.01% 3016
2023
Q2 		$20.7M Buy
95,500
+21,600
+29% +$4.63M 0.01% 1177
2023
Q1 		$13.4M Sell
73,900
-6,400
-8% -$1.22M 0.01% 1340
2022
Q4 		$15.8M Sell
80,300
-31,100
-28% -$6.67M 0.01% 1187
2022
Q3 		$25.1M Buy
111,400
+7,300
+7% +$1.48M 0.01% 894
2022
Q2 		$13.2M Buy
104,100
+63,900
+159% +$7.34M 0.01% 1453
2022
Q1 		$5.1M Buy
40,200
+21,400
+114% +$2.41M ﹤0.01% 2997
2021
Q4 		$2.46M Buy
18,800
+15,200
+422% +$1.96M ﹤0.01% 4049
2021
Q3 		$440K Sell
3,600
-1,100
-23% -$127K ﹤0.01% 7525
2021
Q2 		$536K Buy
4,700
+900
+24% +$105K ﹤0.01% 7102
2021
Q1 		$457K Buy
+3,800
New +$430K ﹤0.01% 6971
2020
Q3 		– Sell
-14,100
Closed -$1.57M – 8135
2020
Q2 		$1.57M Buy
+14,100
New +$1.23M ﹤0.01% 3399

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jane Street's KRTX Position: Q1 2024 in Review

Jane Street sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,456 shares — an estimated $1.09M sold.

Jane Street first reported a position in KRTX in Q4 2019 and held it in 12 quarters. The position peaked at $13M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Jane Street reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 3,456 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.09M.
  • Jane Street first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Jane Street's Karuna Therapeutics, Inc. Common Stock position peaked at $13M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.